Journal of the American Academy of Dermatology

As the official publication of the American Academy of Dermatology, the Journal is dedicated to the clinical and continuing education needs of the entire dermatologic community and is internationally known as the leading journal in the field. Original, peer-reviewed articles cover clinical and investigative studies, treatments, new diagnostic techniques, and other topics relating to the prevention, diagnosis, and treatment of disorders of the skin. Included are CME articles based on the Core Curriculum of the American Academy of Dermatology. The Journal is ranked 3rd of 43 journals in the Dermatology category in the 2009 Journal Citation Reports®, published by Thomson Reuters, and has an Impact Factor of 4.081. The Journal of the American Academy of Dermatology is also recommended for purchase in the Brandon-Hill study, Selected List of Books and Journals for the Small Medical Library.

Publisher
Elsevier
Impact factor
4.274 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Combination therapy for rosacea shows improved response rates

Combining ivermectin cream (IVM) and doxycycline modified-release capsules (DMR) can improve response rates for patients with severe rosacea, according to a study recently published in the Journal of the American Academy ...

Oncology & Cancer

Intralesional IL-2 promising for cutaneous melanoma metastases

(HealthDay)—Patients with cutaneous melanoma metastases have excellent response to intralesional interleukin 2 (IL-2) administered concomitantly with topical imiquimod and a retinoid cream, according to a case series published ...

Diseases, Conditions, Syndromes

Spironolactone seems effective for female pattern hair loss

(HealthDay)—Spironolactone may be an effective treatment for female pattern hair loss (FPHL), especially among patients with signs of hyperandrogenism, according to a study published in the October issue of the Journal ...

Health

Cellulitis often misdiagnosed in inpatient setting

(HealthDay)—Cellulitis is frequently misdiagnosed in the inpatient setting, according to research published in the July issue of the Journal of the American Academy of Dermatology.

Diseases, Conditions, Syndromes

Study looks at costs for moderate to severe plaque psoriasis

(HealthDay)—Most patients with moderate to severe plaque psoriasis (MSPP) are prescribed medications, with six-month total direct costs of $11,291 per patient, according to a study published in the October issue of the ...

Diseases, Conditions, Syndromes

Rosacea linked to various comorbid conditions

(HealthDay)—Rosacea is associated with various comorbid conditions, including, but not limited to, allergies, respiratory diseases, and gastrointestinal diseases, according to a study published in the October issue of the ...

page 1 from 19